[HTML][HTML] Reduction of multiplicity of infections but no change in msp2 genetic diversity in Plasmodium falciparum isolates from Congolese children after introduction …
R Ibara-Okabande, F Koukouikila-Koussounda… - Malaria journal, 2012 - Springer
Background In this first study conducted after the introduction of artemisinin-combination
therapy (ACT), the major objective was to evaluate Plasmodium falciparum genetic diversity …
therapy (ACT), the major objective was to evaluate Plasmodium falciparum genetic diversity …
[引用][C] Reduction of multiplicity of infections but no change in msp2 genetic diversity in Plasmodium falciparum isolates from Congolese children after introduction of …
R Ibara-Okabande… - Malaria …, 2012 - tobias-lib.ub.uni-tuebingen.de
Reduction of multiplicity of infections but no change in msp2 genetic diversity in Plasmodium
falciparum isolates from Congolese children after introduction of artemisinin-combination …
falciparum isolates from Congolese children after introduction of artemisinin-combination …
Reduction of multiplicity of infections but no change in msp2 genetic diversity in Plasmodium falciparum isolates from Congolese children after introduction of …
R Ibara-Okabande… - Malaria …, 2012 - pubmed.ncbi.nlm.nih.gov
Background In this first study conducted after the introduction of artemisinin-combination
therapy (ACT), the major objective was to evaluate Plasmodium falciparum genetic diversity …
therapy (ACT), the major objective was to evaluate Plasmodium falciparum genetic diversity …
Reduction of multiplicity of infections but no change in msp2 genetic diversity in Plasmodium falciparum isolates from Congolese children after introduction of …
R Ibara-Okabande, F Koukouikila-Koussounda… - Malaria Journal, 2012 - go.gale.com
Background In this first study conducted after the introduction of artemisinin-combination
therapy (ACT), the major objective was to evaluate Plasmodium falciparum genetic diversity …
therapy (ACT), the major objective was to evaluate Plasmodium falciparum genetic diversity …
Reduction of multiplicity of infections but no change in msp2 genetic diversity in Plasmodium falciparum isolates from Congolese children after introduction of …
R Ibara-Okabande, F Koukouikila-Koussounda… - 2012 - cabidigitallibrary.org
Background: In this first study conducted after the introduction of artemisinin-combination
therapy (ACT), the major objective was to evaluate Plasmodium falciparum genetic diversity …
therapy (ACT), the major objective was to evaluate Plasmodium falciparum genetic diversity …
Reduction of multiplicity of infections but no change in msp2 genetic diversity in Plasmodium falciparum isolates from Congolese children after introduction of …
R Ibara-Okabande… - Malaria …, 2012 - search.ebscohost.com
Background: In this first study conducted after the introduction of artemisinin-combination
therapy (ACT), the major objective was to evaluate Plasmodium falciparum genetic diversity …
therapy (ACT), the major objective was to evaluate Plasmodium falciparum genetic diversity …
[HTML][HTML] Reduction of multiplicity of infections but no change in msp2 genetic diversity in Plasmodium falciparum isolates from Congolese children after introduction of …
R Ibara-Okabande, F Koukouikila-Koussounda… - Malaria …, 2012 - ncbi.nlm.nih.gov
Background In this first study conducted after the introduction of artemisinin-combination
therapy (ACT), the major objective was to evaluate Plasmodium falciparum genetic diversity …
therapy (ACT), the major objective was to evaluate Plasmodium falciparum genetic diversity …
[引用][C] Reduction of multiplicity of infections but no change in msp2 genetic diversity in Plasmodium falciparum isolates from Congolese children after introduction of …
R Ibara-Okabande… - Malaria …, 2012 - ub01.uni-tuebingen.de
Reduction of multiplicity of infections but no change in msp2 genetic diversity in Plasmodium
falciparum isolates from Congolese children after introduction of artemisinin-combination …
falciparum isolates from Congolese children after introduction of artemisinin-combination …
Reduction of multiplicity of infections but no change in msp2 genetic diversity in Plasmodium falciparum isolates from Congolese children after introduction of …
R Ibara-Okabande, F Koukouikila-Koussounda… - Malaria …, 2012 - europepmc.org
Background In this first study conducted after the introduction of artemisinin-combination
therapy (ACT), the major objective was to evaluate Plasmodium falciparum genetic diversity …
therapy (ACT), the major objective was to evaluate Plasmodium falciparum genetic diversity …
Reduction of multiplicity of infections but no change in msp2 genetic diversity in Plasmodium falciparum isolates from Congolese children after introduction of …
R Ibara-Okabande, F Koukouikila-Koussounda… - Malaria …, 2012 - search.proquest.com
Background: In this first study conducted after the introduction of artemisinin-combination
therapy (ACT), the major objective was to evaluate Plasmodium falciparum genetic diversity …
therapy (ACT), the major objective was to evaluate Plasmodium falciparum genetic diversity …